-transparent.png){kind=logo}
Expression of the apoptosis-inhibitory protein Bcl-2 has frequently been detected in human cancer including mammary carcinoma. The functional significance of its expression has been well established in experimental tumors of the lymphoid system, however, remains to be elucidated for epithelial tumors. In order to assess the role of Bcl-2 in mammary tumorigenesis we have generated WAP-bcl-2 transgenic mice. The strong overexpression of Bcl-2 in lactating mammary glands was preserved during early postlactational involution and apoptosis of alveolar epithelial cells was prevented without influencing the dedifferentiation of the milk-producing epithelium. Although Bcl-2 overexpression was not sufficient to induce spontaneous tumors it, however, led to an accelerated development of MMTV myc transgene-induced mammary tumors. In the mammary glands of MMTV myc transgenic mice, a high proportion of apoptotic cells was detected which was significantly reduced in the mammary glands of WAP-bcl-2/ MMTV myc double transgenic mice. Taken together, these results suggest that Bcl-2 contributes to mammary tumorigenesis by inhibiting apoptosis.
R Jäger, and
U Herzer, and
J Schenkel, and
H Weiher
September 1995,
Cancer research,
R Jäger, and
U Herzer, and
J Schenkel, and
H Weiher
August 1999,
Anatomia, histologia, embryologia,
R Jäger, and
U Herzer, and
J Schenkel, and
H Weiher
April 2014,
BMC cancer,
R Jäger, and
U Herzer, and
J Schenkel, and
H Weiher
January 2004,
Journal of mammary gland biology and neoplasia,
R Jäger, and
U Herzer, and
J Schenkel, and
H Weiher
October 2004,
British journal of cancer,
R Jäger, and
U Herzer, and
J Schenkel, and
H Weiher
October 1999,
Cancer research,
R Jäger, and
U Herzer, and
J Schenkel, and
H Weiher
June 1993,
Leukemia,
R Jäger, and
U Herzer, and
J Schenkel, and
H Weiher
January 2002,
Oncogene,
R Jäger, and
U Herzer, and
J Schenkel, and
H Weiher
March 1999,
The American journal of physiology,
R Jäger, and
U Herzer, and
J Schenkel, and
H Weiher
July 2004,
Oncogene,
